Hepatocellular carcinoma in survivors after Fontan operation

Authors

Yuli Y. Kim, Hospital of the University of Pennsylvania
Gentian Lluri, University of California Los Angeles
Christiane Haeffele, Stanford University School of Medicine
Tami Daugherty, Stanford University School of Medicine
Richard A. Krasuski, Duke University Health System
John D. Serfas, Duke University Health System
R. Andrew De Freitas, Advocate Health - Midwest
Avaliese Porlier, Advocate Health - Midwest
Adam M. Lubert, University of Cincinnati College of Medicine
Fred M. Wu, Brigham and Women's Hospital
Anne Marie Valente, Brigham and Women's Hospital
Eric V. Krieger, University of Washington Medical Center
Jonathan Buber, University of Washington Medical Center
Fred H. Rodriguez, Emory University School of Medicine
Scott Gaignard, Emory University School of Medicine
Anita Saraf, University of Pittsburgh Medical Center
Morgan Hindes, University of Pittsburgh Medical Center
Michael G. Earing, Advocate Health - MidwestFollow
et al

Recommended Citation

Kim YY, Lluri G, Haeffele C, et al. Hepatocellular carcinoma in survivors after Fontan operation: a case-control study. Eur Heart J. 2024;45(16):1477-1480. doi:10.1093/eurheartj/ehad788

Document Type

Article

PubMed ID

38085593